Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Else A. Tolner is active.

Publication


Featured researches published by Else A. Tolner.


Annals of Neurology | 2015

Cerebellar output controls generalized spike-and-wave discharge occurrence

Lieke Kros; Oscar H.J. Eelkman Rooda; Jochen K. Spanke; Parimala Alva; Marijn N. van Dongen; Athanasios Karapatis; Else A. Tolner; Christos Strydis; Neil Davey; Beerend H. J. Winkelman; Mario Negrello; Wouter A. Serdijn; Volker Steuber; Arn M. J. M. van den Maagdenberg; Chris I. De Zeeuw; Freek E. Hoebeek

Disrupting thalamocortical activity patterns has proven to be a promising approach to stop generalized spike‐and‐wave discharges (GSWDs) characteristic of absence seizures. Here, we investigated to what extent modulation of neuronal firing in cerebellar nuclei (CN), which are anatomically in an advantageous position to disrupt cortical oscillations through their innervation of a wide variety of thalamic nuclei, is effective in controlling absence seizures.


Analytical Chemistry | 2014

Automatic Registration of Mass Spectrometry Imaging Data Sets to the Allen Brain Atlas

Walid M. Abdelmoula; Ricardo J. Carreira; Reinald Shyti; Benjamin Balluff; René J. M. van Zeijl; Else A. Tolner; Boudewijn F. P. Lelieveldt; Arn M. J. M. van den Maagdenberg; Liam A. McDonnell; Jouke Dijkstra

Mass spectrometry imaging holds great potential for understanding the molecular basis of neurological disease. Several key studies have demonstrated its ability to uncover disease-related biomolecular changes in rodent models of disease, even if highly localized or invisible to established histological methods. The high analytical reproducibility necessary for the biomedical application of mass spectrometry imaging means it is widely developed in mass spectrometry laboratories. However, many lack the expertise to correctly annotate the complex anatomy of brain tissue, or have the capacity to analyze the number of animals required in preclinical studies, especially considering the significant variability in sizes of brain regions. To address this issue, we have developed a pipeline to automatically map mass spectrometry imaging data sets of mouse brains to the Allen Brain Reference Atlas, which contains publically available data combining gene expression with brain anatomical locations. Our pipeline enables facile and rapid interanimal comparisons by first testing if each animals tissue section was sampled at a similar location and enabling the extraction of the biomolecular signatures from specific brain regions.


Journal of Proteomics | 2012

Imaging mass spectrometry to visualize biomolecule distributions in mouse brain tissue following hemispheric cortical spreading depression

Emrys A. Jones; Reinald Shyti; René J. M. van Zeijl; Sandra H. van Heiningen; Michel D. Ferrari; André M. Deelder; Else A. Tolner; Arn M. J. M. van den Maagdenberg; Liam A. McDonnell

MALDI mass spectrometry can simultaneously measure hundreds of biomolecules directly from tissue. Using essentially the same technique but different sample preparation strategies, metabolites, lipids, peptides and proteins can be analyzed. Spatially correlated analysis, imaging MS, enables the distributions of these biomolecular ions to be simultaneously measured in tissues. A key advantage of imaging MS is that it can annotate tissues based on their MS profiles and thereby distinguish biomolecularly distinct regions even if they were unexpected or are not distinct using established histological and histochemical methods e.g. neuropeptide and metabolite changes following transient electrophysiological events such as cortical spreading depression (CSD), which are spreading events of massive neuronal and glial depolarisations that occur in one hemisphere of the brain and do not pass to the other hemisphere , enabling the contralateral hemisphere to act as an internal control. A proof-of-principle imaging MS study, including 2D and 3D datasets, revealed substantial metabolite and neuropeptide changes immediately following CSD events which were absent in the protein imaging datasets. The large high dimensionality 3D datasets make even rudimentary contralateral comparisons difficult to visualize. Instead non-negative matrix factorization (NNMF), a multivariate factorization tool that is adept at highlighting latent features, such as MS signatures associated with CSD events, was applied to the 3D datasets. NNMF confirmed that the protein dataset did not contain substantial contralateral differences, while these were present in the neuropeptide dataset.


Analytical Chemistry | 2015

Comprehensive analysis of the mouse brain proteome sampled in mass spectrometry imaging.

Bram Heijs; Ricardo J. Carreira; Else A. Tolner; Arnoud H. de Ru; Arn M. J. M. van den Maagdenberg; Peter A. van Veelen; Liam A. McDonnell

On-tissue enzymatic digestion is performed in mass spectrometry imaging (MSI) experiments to access larger proteins and to assign protein identities. Most on-tissue digestion MSI studies have focused on method development rather than identifying the molecular features observed. Herein, we report a comprehensive study of the mouse brain proteome sampled by MSI. Using complementary proteases, we were able to identify 5337 peptides in the matrix-assisted laser desorption/ionization (MALDI) matrix, corresponding to 1198 proteins. 630 of these peptides, corresponding to 280 proteins, could be assigned to peaks in MSI data sets. Gene ontology and pathway analyses revealed that many of the proteins are involved in neurodegenerative disorders, such as Alzheimers, Parkinsons, and Huntingtons disease.


Journal of the American Society for Mass Spectrometry | 2015

Large-Scale Mass Spectrometry Imaging Investigation of Consequences of Cortical Spreading Depression in a Transgenic Mouse Model of Migraine

Ricardo J. Carreira; Reinald Shyti; Benjamin Balluff; Walid M. Abdelmoula; Sandra H. van Heiningen; René J. M. van Zeijl; Jouke Dijkstra; Michel D. Ferrari; Else A. Tolner; Liam A. McDonnell; Arn M. J. M. van den Maagdenberg

AbstractCortical spreading depression (CSD) is the electrophysiological correlate of migraine aura. Transgenic mice carrying the R192Q missense mutation in the Cacna1a gene, which in patients causes familial hemiplegic migraine type 1 (FHM1), exhibit increased propensity to CSD. Herein, mass spectrometry imaging (MSI) was applied for the first time to an animal cohort of transgenic and wild type mice to study the biomolecular changes following CSD in the brain. Ninety-six coronal brain sections from 32 mice were analyzed by MALDI-MSI. All MSI datasets were registered to the Allen Brain Atlas reference atlas of the mouse brain so that the molecular signatures of distinct brain regions could be compared. A number of metabolites and peptides showed substantial changes in the brain associated with CSD. Among those, different mass spectral features showed significant (t-test, P < 0.05) changes in the cortex, 146 and 377 Da, and in the thalamus, 1820 and 1834 Da, of the CSD-affected hemisphere of FHM1 R192Q mice. Our findings reveal CSD- and genotype-specific molecular changes in the brain of FHM1 transgenic mice that may further our understanding about the role of CSD in migraine pathophysiology. The results also demonstrate the utility of aligning MSI datasets to a common reference atlas for large-scale MSI investigations. Graphical Abstractᅟ


Critical Care Medicine | 2016

Slowing Down of Recovery as Generic Risk Marker for Acute Severity Transitions in Chronic Diseases.

Marcel G. M. Olde Rikkert; Vasilis Dakos; Timothy G. Buchman; Rob J. de Boer; Leon Glass; Angélique O. J. Cramer; Simon A. Levin; Egbert H. van Nes; George Sugihara; Michel D. Ferrari; Else A. Tolner; Ingrid A. van de Leemput; Joep Lagro; René J. F. Melis; Marten Scheffer

Objective:We propose a novel paradigm to predict acute attacks and exacerbations in chronic episodic disorders such as asthma, cardiac arrhythmias, migraine, epilepsy, and depression. A better generic understanding of acute transitions in chronic dynamic diseases is increasingly important in critical care medicine because of the higher prevalence and incidence of these chronic diseases in our aging societies. Data Sources:PubMed, Medline, and Web of Science. Study Selection:We selected studies from biology and medicine providing evidence of slowing down after a perturbation as a warning signal for critical transitions. Data Extraction:Recent work in ecology, climate, and systems biology has shown that slowing down of recovery upon perturbations can indicate loss of resilience across complex, nonlinear biologic systems that are approaching a tipping point. This observation is supported by the empiric studies in pathophysiology and controlled laboratory experiments with other living systems, which can flip from one state of clinical balance to a contrasting one. We discuss examples of such evidence in bodily functions such as blood pressure, heart rate, mood, and respiratory regulation when a tipping point for a transition is near. Conclusions:We hypothesize that in a range of chronic episodic diseases, indicators of critical slowing down, such as rising variance and temporal correlation, may be used to assess the risk of attacks, exacerbations, and even mortality. Identification of such early warning signals over a range of diseases will enhance the understanding of why, how, and when attacks and exacerbations will strike and may thus improve disease management in critical care medicine.


Metabolomics | 2016

Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue

Clara Esteve; Else A. Tolner; Reinald Shyti; Arn M. J. M. van den Maagdenberg; Liam A. McDonnell

The detection of small polar compounds such as amino neurotransmitters by MALDI mass spectrometry imaging has been hindered by low-detection sensitivity and background interferences. Recently, several of on-tissue chemical derivatization strategies have been independently reported that enable their detection. Here, we present a comparison between these methods, and demonstrate the visualization of the distributions of up to 23 amino metabolites in tissue. We applied this methodology to detect alterations of these compounds after inducing an experimental cortical spreading depression in mouse brain, which causes profound transient alterations in key neurotransmitters in one hemisphere and is relevant for migraine and various other neurological disorders.


Analytical Chemistry | 2014

Automatic Generic Registration of Mass Spectrometry Imaging Data to Histology Using Nonlinear Stochastic Embedding

Walid M. Abdelmoula; Karolina Škrášková; Benjamin Balluff; Ricardo J. Carreira; Else A. Tolner; Boudewijn P. F. Lelieveldt; Laurens van der Maaten; Hans Morreau; Arn M. J. M. van den Maagdenberg; Ron M. A. Heeren; Liam A. McDonnell; Jouke Dijkstra

The combination of mass spectrometry imaging and histology has proven a powerful approach for obtaining molecular signatures from specific cells/tissues of interest, whether to identify biomolecular changes associated with specific histopathological entities or to determine the amount of a drug in specific organs/compartments. Currently there is no software that is able to explicitly register mass spectrometry imaging data spanning different ionization techniques or mass analyzers. Accordingly, the full capabilities of mass spectrometry imaging are at present underexploited. Here we present a fully automated generic approach for registering mass spectrometry imaging data to histology and demonstrate its capabilities for multiple mass analyzers, multiple ionization sources, and multiple tissue types.


Journal of Cerebral Blood Flow and Metabolism | 2017

Optogenetic induction of cortical spreading depression in anesthetized and freely behaving mice

Thijs Houben; Inge Cm Loonen; Serapio M. Baca; Maarten Schenke; Johanna H. Meijer; Michel D. Ferrari; Gisela M. Terwindt; Rob A. Voskuyl; Andrew Charles; Arn M. J. M. van den Maagdenberg; Else A. Tolner

Cortical spreading depression, which plays an important role in multiple neurological disorders, has been studied primarily with experimental models that use highly invasive methods. We developed a relatively non-invasive optogenetic model to induce cortical spreading depression by transcranial stimulation of channelrhodopsin-2 ion channels expressed in cortical layer 5 neurons. Light-evoked cortical spreading depression in anesthetized and freely behaving mice was studied with intracortical DC-potentials, multi-unit activity and/or non-invasive laser Doppler flowmetry, and optical intrinsic signal imaging. In anesthetized mice, cortical spreading depression induction thresholds and propagation rates were similar for invasive (DC-potential) and non-invasive (laser Doppler flowmetry) recording paradigms. Cortical spreading depression-related vascular and parenchymal optical intrinsic signal changes were similar to those evoked with KCl. In freely behaving mice, DC-potential and multi-unit activity recordings combined with laser Doppler flowmetry revealed cortical spreading depression characteristics comparable to those under anesthesia, except for a shorter cortical spreading depression duration. Cortical spreading depression resulted in a short increase followed by prolonged reduction of spontaneous active behavior. Motor function, as assessed by wire grip tests, was transiently and unilaterally suppressed following a cortical spreading depression. Optogenetic cortical spreading depression induction has significant advantages over current models in that multiple cortical spreading depression events can be elicited in a non-invasive and cell type-selective fashion.


Proteomics | 2016

Funnel‐freezing versus heat‐stabilization for the visualization of metabolites by mass spectrometry imaging in a mouse stroke model

Inge A. Mulder; Clara Esteve; Marieke J.H. Wermer; Mathias Hoehn; Else A. Tolner; Arn M. J. M. van den Maagdenberg; Liam A. McDonnell

Tissue preparation is the key to a successful matrix‐assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) experiment. Rapid post‐mortem changes contribute a significant challenge to the use of MSI approaches for the analysis of peptides and metabolites. In this technical note we aimed to compare the tissue fixation method ex‐vivo heat‐stabilization with in‐situ funnel‐freezing in a middle cerebral artery occlusion (MCAo) mouse model of stroke, which causes profound alterations in metabolite concentrations. The influence of the duration of the thaw‐mounting of the tissue sections on metabolite stability was also determined. We demonstrate improved stability and biomolecule visualization when funnel‐freezing was used to sacrifice the mouse compared with heat‐stabilization. Results were further improved when funnel‐freezing was combined with fast thaw‐mounting of the brain sections.

Collaboration


Dive into the Else A. Tolner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michel D. Ferrari

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Reinald Shyti

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Liam A. McDonnell

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jouke Dijkstra

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Walid M. Abdelmoula

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Else Eising

Leiden University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge